Comparative study of esketamine and racemic ketamine in treatment-resistant depression
Medicine September 1, 2018 Fernanda S. Correia-Melo, Gustavo C. Leal, Michelle S. Carvalho et al. 61 citations
INTRODUCTION: The use of ketamine as an option in the treatment of depressive disorder is growing rapidly, supported by numerous clinical trials attesting its efficacy and safety. Esketamine, the S (+) enantiomer of ketamine, is the most widely used form in the anesthetic environment in some countries, and new studies have shown that it may also be effective in depression and with better...